Logo-bma
Biomed adv. 2026;3(1): 16-20. doi: 10.34172/bma.59

Review Article

Glucagon‑like peptide‑1–based agonists as novel targets in obesity management: Mechanistic pathways and adverse effects

Naimeh Mesri Alamdari * ORCID

Cited by CrossRef:



Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.